Prenatal testing plays a significant role in the early detection of genetic predispositions to cancer. Certain genetic mutations, such as those found in the BRCA1 and BRCA2 genes, can increase the likelihood of developing cancers like breast and ovarian cancer later in life. Identifying these mutations early can help in planning future medical care and surveillance strategies.
